Hsp90 as a Gatekeeper of Tumor Angiogenesis: Clinical Promise and Potential Pitfalls

Tumor vascularization is an essential modulator of early tumor growth, progression, and therapeutic outcome. Although antiangiogenic treatments appear promising, intrinsic and acquired tumor resistance contributes to treatment failure. Clinical inhibition of the molecular chaperone heat shock protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Bohonowych, J. E., Gopal, U., Isaacs, J. S.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902748/
https://www.ncbi.nlm.nih.gov/pubmed/20628489
http://dx.doi.org/10.1155/2010/412985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902748/
https://www.ncbi.nlm.nih.gov/pubmed/20628489
http://dx.doi.org/10.1155/2010/412985

Ejemplares similares